Kindstar Globalgene Technology

SEHK:9960 Stock Report

Mkt Cap: HK$1.9b

Kindstar Globalgene Technology Past Performance

How has Kindstar Globalgene Technology performed over the past 5 years?

Past Performance Score


Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 9960 has a high level of non-cash earnings.

Growing Profit Margin: 9960 became profitable in the past.

Past Earnings Growth Analysis

Earnings Trend: 9960 has become profitable over the past 5 years, growing earnings by -24.6% per year.

Accelerating Growth: 9960 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 9960 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (1%).

Return on Equity

High ROE: 9960's Return on Equity (3.8%) is considered low.

Discover strong past performing companies